Home » Topics » Regulatory » Patents

Patents
RSS

Cytomegalovirus DNA polymerase inhibitors discovered at the University of Alberta

Sep. 29, 2021

Peking University presents new boron-carrying agents

Sep. 29, 2021

Shanghai Zheye Biotechnology divulges G12C mutant GTPase KRAS inhibitors

Sep. 29, 2021

New PDE4 inhibitors divulged by Suzhou Longbiotech Pharmaceuticals

Sep. 28, 2021

Hanyang University discovers MAPK10 inhibitors

Sep. 28, 2021

New HDAC6 inhibitors identified at Chong Kun Dang Pharmaceutical

Sep. 28, 2021

U.S. Department of Health & Human Services patents T-cell receptors against mutated RAS

Sep. 28, 2021

NLRP3 inflammasome inhibitors patented by Cadila Healthcare

Sep. 27, 2021

Servier discovers nuclear factor erythroid 2-related factor 2 activators

Sep. 27, 2021

Kallyope presents new free fatty acid FFA1 receptor agonists

Sep. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...